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1. Introduction 
One of the more striking, but least studied, aspects 
of thyroid action is its effect on the hormone respon- 
siveness of tissues. The action of lipolytic hormones 
such as glucagon, catecholamines and ACTH is 
markedly reduced in adipose tissue following thyroid- 
ectomy, while the action of insulin is potentiated after 
administration of thyroid hormone [l] . Insulin and 
glucagon both modulate the cyclic nucleotide content 
of liver and adipose tissue, insulin causing a rapid and 
transient rise in cGMP [2,3] and glucagon a marked 
rise of CAMP [4,5] . The reports that there is an 
increase of CAMP- and cGMP-phosphodiesterases in
adipose tissue following thyroidectomy [6-91 may 
well be particularly relevant to these tissue responses 
to hormones. 
The similarities in the response to thyroidectomy 
of the enzymes of carbohydrate metabolism and of 
fatty acid synthesis in rat liver and adipose tissue [lo] 
prompted the present study of the enzymes regulating 
the tissue level of the cyclic nucleotides in rat liver. 
Changes in the balance of the enzymes adjusting the 
tissue content of these nucleotides could provide a 
common locus for thyroid action in a number of 
tissues responsive to insulin and glucagon and thus act 
as a unifying factor in the coordination of liver and 
adipose tissue metabolism. 
2. Materials and methods 
2.1. Animals 
Adult male albino rats of the Wistar strain were 
thyroidectomized or sham-operated: thyroidectomized 
rats were given 1% calcium gluconate in the drinking 
water: both groups were fed a standard laboratory 
cube diet (MRC 41b) and were used two weeks after 
operation. 
2.2. Enzyme and cyclic nucleo tide assays 
The preparation of liver extracts and membrane 
fractions was as described by Sapag-Hagar and 
Greenbaum [ 111. CAMP- and cGMP-phosphodiesterases 
were estimated by the two-step procedure of Thompson 
et al. [ 121 using 10 PM or 100 PM CAMP or cGMP for 
the low- and high-K, phosphodiesterases [ 1 l] . 
Adenylate cyclase activity was estimated by the 
method of Davis and Lazarus [ 131 as modified by 
Sapag-Hagar and Greenbaum [ 1 l] . Enzyme activities 
are expressed as milliunits, 1 mU being equivalent to 
1 nmol of CAMP or cGMP hydrolysed or produced/ 
min at 37°C. 
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CAMP and cCMP were estimated by radioisotope 3. Results 
dilution procedures; CAMP by the method of Tovey 
et al. [ 141 using a binding protein prepared from beef The most striking observation was the contrasting 
muscle and cGMP by a radioimmunoassay procedure responses of the two phosphodiesterases in both the 
using a commercial kit from the Radiochemical Centre, soluble and particlebound fractions. Thyroidectomy 
Amersham, Bucks, England. significantly increased the activity of both the low- 
Table 1 
Activity of low- and high-Km CAMP- and cGMP-phosphodiesterases, and of 
adenylate cyclase of liver from thyroidectomized and control rats together 
with tissue content of cyclic nucleotides 
Control Thyroidectomized % P 
TX 
C 
No. of observations 7 12 
Body weight (g) 338 +_ 18 255 +7 
Liver weight (g) 14.5 +_ 0.4 10.2 + 0.4 
Liver weight/100 body wt. g 4.31 f 0.14 4.01 + 0.09 
Cyclic nucleotide phosphodiesterase activity (mu/g) 
4000 X g membrane fraction 
Low-K, CAMP-PDE 1.85 f 0.10 2.31 + 0.08 
High-K, CAMP-PDE 18.0 c 0.48 20.4 f 0.68 
Low-K, cGMP-PDE 5.11 * 0.39 5.66 f 0.15 
High-K, cCMP-PDE 18.9 ?r 1.44 20.9 + 1.14 
105 000 X pellet fraction g 
Low-K, CAMP-PDE 1.87 f 0.03 2.41 k 0.12 
High-K, CAMP-PDE 13.9 +_ 0.74 14.3 f 0.45 
Low-K, cGMP-PDE 4.47 f 0.31 5.25 f 0.19 
High-K, cGMP-PDE 12.6 ?: 0.9 12.6 + 0.7 
105 000 X supernatant fraction g 
Low-K, CAMP-PDE 20.9 + 1.8 20.4 f 1.1 
High-K, CAMP-PDE 166 * 12 193 f 8 
Low-K, cCMP-PDE 52.9 + 4.1 69.0 f 3.7 
High-K, cGMP-PDE 150 t 17 200 r 16 
Adenylate cyclase activity (mu/g) 
4000 X membrane fraction g 1.18 r 0.14 1.70 f 0.25 
Total pellet fraction 1.91 f 0.33 1.90 +_ 0.33 
Cyclic nucleotide content (pmol/g) 
CAMP 546 * 28 528 f 22 
cGMP 23.6 * 2.3 23.9 k 2.2 
- 
75 11; 
70 
93 
129 :** 
113 
110 
110 
130 *** 
103 
117 
100 
98 
116 
130 ;* 
133 
144 
100 
97 
101 
Values are given as means * SEM. Fisher’s P values are shown by asterisks; 
*, P < 0.05; **, P < 0.01; ***, P < 0.001 
Enzymes (CBN Recommendations 1972) CAMP-phosphodiesterase also 3’:5’-cyclic 
nucleotidase (EC 3.1.4.17), abbreviated in table 1 to CAMP-PDE and cGMP-PDE; 
adenylate cyclase (EC 4.6.1.1) 
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and high-K, CAMP phosphodiesterases (the former 
to an appreciably greater extent) of the particle- and 
membrane-bound forms of the enzyme while having 
no effect on the two soluble forms. On the other hand, 
thyroidectomy significantly increased the activity of 
the two cCMP-phosphodiesterases of the soluble frac- 
tion while leaving the particulatebound forms unaffect- 
ed (table 1). Thus, the contrasting intracellular sites 
for the regulation of CAMP and cGMP hydrolysis by 
thyroid hormone is apparent. 
The adenylate cyclase activity of the membrane 
fraction was increased by some 40% following thyroid- 
ectomy (Fishers P = 0.08) but no alteration was 
observed in the activity of the total particulate frac- 
tion. The tissue content of CAMP and of cGMP in 
freeze-clamped liver was also unchanged. 
4. Discussion 
The changes in CAMP- and cGMP-phosphodiesterases 
in the liver of thyroidectomized rats reported here, 
parallel those found in adipose tissue in this condition 
as reported [6-9,151. The similarity between these 
results on different tissues perhaps points to a unifying 
hypothesis for the action of thyroid hormone on two 
major insulin- and glucagon-responsive tissues, liver 
and adipose tissue. 
In liver, thyroidectomy results in a marked decrease 
in both major routes of glucose oxidation, of lipo- 
genesis and gluconeogenesis [10,16-181 . The hepatic 
enzyme profile of thyroidectomized rats shows many 
marked similarities to that of insulin-deficient rats, 
particularly in respect to the decrease in activity of 
glucokinase, pyruvate kinase, the oxidative enzymes of 
the pentose phosphate pathway and the enzymes 
related to lipid synthesis (citrate lyase, fatty acid 
synthetase and ‘malic enzyme’) [lo] . The remarkable 
parallelism between changes in hepatic and adipose 
tissue enzymes related to glucose oxidation and lipid 
synthesis was also emphasized by Bacquer et al. [lo] . 
Further, there is substantial evidence that both liver 
and adipose tissue from thyroidectomized rats exhibit 
changes which can be attributed to a glucagon-insensi- 
tive state, namely, in liver, a decreased rate of gluconeo- 
genesis, as shown by studies with perfused liver 
presented with lactate as substrate [ 191 and by changes 
in key gluconeogenic enzymes, pyruvate carboxylase 
and phosphoenolpyruvate carboxykinase [ 161 and, in 
adipose tissue, by a decreased lipolytic response to 
glucagon and epinephrine [6-9,151. 
Thyroidectomy, and the accompanying rise in the 
potential rate of hydrolysis of CAMP and cGMP, could 
effectively counteract the signals received at the plasma 
cell membrane from insulin (with the associated rise 
in cGMP) and glucagon (with the associated rise in 
CAMP) in both liver and adipose tissue and, in this 
sense, thyroid hormone could exert a ‘permissive’ role 
in insulin and glucagon action. The observations by 
Correze et al. [9] that insulin raises still further the 
CAMP- and cGMP-phosphodiesterases of adipose tissue 
from thyroidectomized animals, but is without effect 
on the cGMP-phosphodiesterase of intact animals, 
points to the possibility of an augmentation of the 
modulating activity of thyroidectomy of the response 
of the cells to external hormones. It is interesting to 
note that Nunez et al. [20] have also used the word 
‘permissive’ in their discussion of the action of thyroid 
hormones. Alterations in the level of circulating 
thyroid hormone would thus reset the response of 
tissues to rapidly changing hormones such as insulin, 
glucagon and catecholamines by regulation of the 
effective cyclic nucleotide level via changes in the 
tissue CAMP- and cGMP-phosphodiesterase activity. 
Thyroxine and tri-iodothyronine may occupy a unique 
position among hormones in that they probably 
affect an exceptionally wide range of cell types and 
in that their blood levels do not normally undergo 
large fluctuations [21] , characteristics emphasizing 
the possibility of their exerting a generalized ‘permis- 
sive’ role. 
The importance of compartmentation of cyclic 
nucleotides, discussed by many previous authors 
[22-241 , is again illustrated by the present results; 
both by the observation that no ‘steady-state’ change 
in the cyclic nucleotides of freeze-clamped liver is 
apparent after thyroidectomy, despite the rise in 
CAMP- and cGMP-phosphodiesterase activity, and by 
the differing intracellular locations of the hormone- 
sensitive cyclic nucleotide phosphodiesterases. 
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